You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Medtronic
Harvard Business School
Johnson and Johnson
AstraZeneca

Last Updated: September 18, 2020

DrugPatentWatch Database Preview

CEFTAZIDIME Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Drug patent expirations by year for CEFTAZIDIME
Recent Clinical Trials for CEFTAZIDIME

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
AllerganPhase 2
PfizerPhase 2
AllerganPhase 1

See all CEFTAZIDIME clinical trials

Pharmacology for CEFTAZIDIME
Medical Subject Heading (MeSH) Categories for CEFTAZIDIME

US Patents and Regulatory Information for CEFTAZIDIME

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acs Dobfar CEFTAZIDIME ceftazidime INJECTABLE;INJECTION 062640-002 Nov 20, 1985 AP RX No No   Start Trial   Start Trial   Start Trial
Aurobindo Pharma Ltd CEFTAZIDIME ceftazidime INJECTABLE;INJECTION 065482-001 May 28, 2010 DISCN No No   Start Trial   Start Trial   Start Trial
Acs Dobfar CEFTAZIDIME ceftazidime INJECTABLE;INJECTION 062640-001 Nov 20, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Baxter Hlthcare CEFTAZIDIME SODIUM IN PLASTIC CONTAINER ceftazidime sodium INJECTABLE;INJECTION 063221-001 Apr 29, 1993 DISCN No No   Start Trial   Start Trial   Start Trial
Aurobindo Pharma Ltd CEFTAZIDIME ceftazidime INJECTABLE;INJECTION 065481-001 May 28, 2010 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
Johnson and Johnson
Dow
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.